RSS

AbbVie

Data and analytics company, GlobalData, has revealed that biosimilars to Humira will have significant uptake across Europe this year as a result of 10–20% lower prices compared with the originator brand. more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Biogen and AbbVie have announced the voluntary global withdrawal of Zinbryta (daclizumab) — a treatment for relapsing multiple sclerosis (MS) — in the best interests of patient safety. more

News

Biopharmaceutical companies, AbbVie and Bristol-Myers Squibb, have announced the formation of a clinical research collaboration to evaluate a combination therapeutic regimen for the treatment of advanced solid tumours. more

News

Abbvie, Sanofi and Novo Nordisk seens as most reputable pharma companies in the UK and industry as a whole ranked third most reputable by general public more

News

Pharma giant AbbVie is to acquire cancer drug developer Stemcentrx in a $10bn deal that is one of the largest private venture-backed acquisitions in history more

News

Contract manufacturing group Vetter has been awarded with the Triumph award by AbbVie, a major biopharmaceutical company. more

News

Pfizer, AstraZeneca, Merck and other Big Pharma companies have signed up to a consortium aimed at accelerating the development of safe and effective therapies for Parkinson’s more

News